Global Antihormonal Cancer Therapies Market Size, Status and Forecast 2024-2031

Report ID: 920883 | Published Date: Sep 2024 | No. of Page: 109 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Antihormonal Cancer Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Radiations
        1.2.3 Drugs
        1.2.4 Surgeries
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Antihormonal Cancer Therapies Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Breast Cancer
        1.3.3 Prostate Cancer
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Antihormonal Cancer Therapies Market Perspective (2016-2027)
    2.2 Antihormonal Cancer Therapies Growth Trends by Regions
        2.2.1 Antihormonal Cancer Therapies Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Antihormonal Cancer Therapies Historic Market Share by Regions (2016-2021)
        2.2.3 Antihormonal Cancer Therapies Forecasted Market Size by Regions (2022-2027)
    2.3 Antihormonal Cancer Therapies Industry Dynamic
        2.3.1 Antihormonal Cancer Therapies Market Trends
        2.3.2 Antihormonal Cancer Therapies Market Drivers
        2.3.3 Antihormonal Cancer Therapies Market Challenges
        2.3.4 Antihormonal Cancer Therapies Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Antihormonal Cancer Therapies Players by Revenue
        3.1.1 Global Top Antihormonal Cancer Therapies Players by Revenue (2016-2021)
        3.1.2 Global Antihormonal Cancer Therapies Revenue Market Share by Players (2016-2021)
    3.2 Global Antihormonal Cancer Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Antihormonal Cancer Therapies Revenue
    3.4 Global Antihormonal Cancer Therapies Market Concentration Ratio
        3.4.1 Global Antihormonal Cancer Therapies Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Antihormonal Cancer Therapies Revenue in 2020
    3.5 Antihormonal Cancer Therapies Key Players Head office and Area Served
    3.6 Key Players Antihormonal Cancer Therapies Product Solution and Service
    3.7 Date of Enter into Antihormonal Cancer Therapies Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Antihormonal Cancer Therapies Breakdown Data by Type
    4.1 Global Antihormonal Cancer Therapies Historic Market Size by Type (2016-2021)
    4.2 Global Antihormonal Cancer Therapies Forecasted Market Size by Type (2022-2027)

5 Antihormonal Cancer Therapies Breakdown Data by Application
    5.1 Global Antihormonal Cancer Therapies Historic Market Size by Application (2016-2021)
    5.2 Global Antihormonal Cancer Therapies Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Antihormonal Cancer Therapies Market Size (2016-2027)
    6.2 North America Antihormonal Cancer Therapies Market Size by Type
        6.2.1 North America Antihormonal Cancer Therapies Market Size by Type (2016-2021)
        6.2.2 North America Antihormonal Cancer Therapies Market Size by Type (2022-2027)
        6.2.3 North America Antihormonal Cancer Therapies Market Size by Type (2016-2027)
    6.3 North America Antihormonal Cancer Therapies Market Size by Application
        6.3.1 North America Antihormonal Cancer Therapies Market Size by Application (2016-2021)
        6.3.2 North America Antihormonal Cancer Therapies Market Size by Application (2022-2027)
        6.3.3 North America Antihormonal Cancer Therapies Market Size by Application (2016-2027)
    6.4 North America Antihormonal Cancer Therapies Market Size by Country
        6.4.1 North America Antihormonal Cancer Therapies Market Size by Country (2016-2021)
        6.4.2 North America Antihormonal Cancer Therapies Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Antihormonal Cancer Therapies Market Size (2016-2027)
    7.2 Europe Antihormonal Cancer Therapies Market Size by Type
        7.2.1 Europe Antihormonal Cancer Therapies Market Size by Type (2016-2021)
        7.2.2 Europe Antihormonal Cancer Therapies Market Size by Type (2022-2027)
        7.2.3 Europe Antihormonal Cancer Therapies Market Size by Type (2016-2027)
    7.3 Europe Antihormonal Cancer Therapies Market Size by Application
        7.3.1 Europe Antihormonal Cancer Therapies Market Size by Application (2016-2021)
        7.3.2 Europe Antihormonal Cancer Therapies Market Size by Application (2022-2027)
        7.3.3 Europe Antihormonal Cancer Therapies Market Size by Application (2016-2027)
    7.4 Europe Antihormonal Cancer Therapies Market Size by Country
        7.4.1 Europe Antihormonal Cancer Therapies Market Size by Country (2016-2021)
        7.4.2 Europe Antihormonal Cancer Therapies Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Antihormonal Cancer Therapies Market Size (2016-2027)
    8.2 Asia-Pacific Antihormonal Cancer Therapies Market Size by Type
        8.2.1 Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2016-2027)
    8.3 Asia-Pacific Antihormonal Cancer Therapies Market Size by Application
        8.3.1 Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2016-2027)
    8.4 Asia-Pacific Antihormonal Cancer Therapies Market Size by Region
        8.4.1 Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Antihormonal Cancer Therapies Market Size (2016-2027)
    9.2 Latin America Antihormonal Cancer Therapies Market Size by Type
        9.2.1 Latin America Antihormonal Cancer Therapies Market Size by Type (2016-2021)
        9.2.2 Latin America Antihormonal Cancer Therapies Market Size by Type (2022-2027)
        9.2.3 Latin America Antihormonal Cancer Therapies Market Size by Type (2016-2027)
    9.3 Latin America Antihormonal Cancer Therapies Market Size by Application
        9.3.1 Latin America Antihormonal Cancer Therapies Market Size by Application (2016-2021)
        9.3.2 Latin America Antihormonal Cancer Therapies Market Size by Application (2022-2027)
        9.3.3 Latin America Antihormonal Cancer Therapies Market Size by Application (2016-2027)
    9.4 Latin America Antihormonal Cancer Therapies Market Size by Country
        9.4.1 Latin America Antihormonal Cancer Therapies Market Size by Country (2016-2021)
        9.4.2 Latin America Antihormonal Cancer Therapies Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Antihormonal Cancer Therapies Market Size (2016-2027)
    10.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type
        10.2.1 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2016-2027)
    10.3 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application
        10.3.1 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2016-2027)
    10.4 Middle East & Africa Antihormonal Cancer Therapies Market Size by Country
        10.4.1 Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Details
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Antihormonal Cancer Therapies Introduction
        11.1.4 AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.1.5 AstraZeneca Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Antihormonal Cancer Therapies Introduction
        11.2.4 Novartis Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Details
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Antihormonal Cancer Therapies Introduction
        11.3.4 Pfizer Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.3.5 Pfizer Recent Development
    11.4 Sanofi
        11.4.1 Sanofi Company Details
        11.4.2 Sanofi Business Overview
        11.4.3 Sanofi Antihormonal Cancer Therapies Introduction
        11.4.4 Sanofi Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.4.5 Sanofi Recent Development
    11.5 Takeda
        11.5.1 Takeda Company Details
        11.5.2 Takeda Business Overview
        11.5.3 Takeda Antihormonal Cancer Therapies Introduction
        11.5.4 Takeda Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.5.5 Takeda Recent Development
    11.6 Roche
        11.6.1 Roche Company Details
        11.6.2 Roche Business Overview
        11.6.3 Roche Antihormonal Cancer Therapies Introduction
        11.6.4 Roche Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.6.5 Roche Recent Development
    11.7 Amgen
        11.7.1 Amgen Company Details
        11.7.2 Amgen Business Overview
        11.7.3 Amgen Antihormonal Cancer Therapies Introduction
        11.7.4 Amgen Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.7.5 Amgen Recent Development
    11.8 Samyang Biopharmaceuticals
        11.8.1 Samyang Biopharmaceuticals Company Details
        11.8.2 Samyang Biopharmaceuticals Business Overview
        11.8.3 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Introduction
        11.8.4 Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.8.5 Samyang Biopharmaceuticals Recent Development
    11.9 Tolmar
        11.9.1 Tolmar Company Details
        11.9.2 Tolmar Business Overview
        11.9.3 Tolmar Antihormonal Cancer Therapies Introduction
        11.9.4 Tolmar Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.9.5 Tolmar Recent Development
    11.10 Bluebird Bio
        11.10.1 Bluebird Bio Company Details
        11.10.2 Bluebird Bio Business Overview
        11.10.3 Bluebird Bio Antihormonal Cancer Therapies Introduction
        11.10.4 Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.10.5 Bluebird Bio Recent Development
    11.11 Bristol-Myers Squibb
        11.11.1 Bristol-Myers Squibb Company Details
        11.11.2 Bristol-Myers Squibb Business Overview
        11.11.3 Bristol-Myers Squibb Antihormonal Cancer Therapies Introduction
        11.11.4 Bristol-Myers Squibb Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.11.5 Bristol-Myers Squibb Recent Development
    11.12 Exelixis
        11.12.1 Exelixis Company Details
        11.12.2 Exelixis Business Overview
        11.12.3 Exelixis Antihormonal Cancer Therapies Introduction
        11.12.4 Exelixis Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.12.5 Exelixis Recent Development
    11.13 Guardant Health
        11.13.1 Guardant Health Company Details
        11.13.2 Guardant Health Business Overview
        11.13.3 Guardant Health Antihormonal Cancer Therapies Introduction
        11.13.4 Guardant Health Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.13.5 Guardant Health Recent Development
    11.14 Illumina
        11.14.1 Illumina Company Details
        11.14.2 Illumina Business Overview
        11.14.3 Illumina Antihormonal Cancer Therapies Introduction
        11.14.4 Illumina Revenue in Antihormonal Cancer Therapies Business (2016-2021)
        11.14.5 Illumina Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Antihormonal Cancer Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Radiations
    Table 3. Key Players of Drugs
    Table 4. Key Players of Surgeries
    Table 5. Key Players of Others
    Table 6. Global Antihormonal Cancer Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Antihormonal Cancer Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Antihormonal Cancer Therapies Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Antihormonal Cancer Therapies Market Share by Regions (2016-2021)
    Table 10. Global Antihormonal Cancer Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Antihormonal Cancer Therapies Market Share by Regions (2022-2027)
    Table 12. Antihormonal Cancer Therapies Market Trends
    Table 13. Antihormonal Cancer Therapies Market Drivers
    Table 14. Antihormonal Cancer Therapies Market Challenges
    Table 15. Antihormonal Cancer Therapies Market Restraints
    Table 16. Global Antihormonal Cancer Therapies Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Antihormonal Cancer Therapies Market Share by Players (2016-2021)
    Table 18. Global Top Antihormonal Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihormonal Cancer Therapies as of 2020)
    Table 19. Ranking of Global Top Antihormonal Cancer Therapies Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Antihormonal Cancer Therapies Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Antihormonal Cancer Therapies Product Solution and Service
    Table 23. Date of Enter into Antihormonal Cancer Therapies Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2016-2021)
    Table 27. Global Antihormonal Cancer Therapies Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Antihormonal Cancer Therapies Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Antihormonal Cancer Therapies Revenue Market Share by Application (2016-2021)
    Table 31. Global Antihormonal Cancer Therapies Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Antihormonal Cancer Therapies Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Antihormonal Cancer Therapies Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Antihormonal Cancer Therapies Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Antihormonal Cancer Therapies Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Antihormonal Cancer Therapies Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Antihormonal Cancer Therapies Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Antihormonal Cancer Therapies Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. AstraZeneca Company Details
    Table 64. AstraZeneca Business Overview
    Table 65. AstraZeneca Antihormonal Cancer Therapies Product
    Table 66. AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 67. AstraZeneca Recent Development
    Table 68. Novartis Company Details
    Table 69. Novartis Business Overview
    Table 70. Novartis Antihormonal Cancer Therapies Product
    Table 71. Novartis Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 72. Novartis Recent Development
    Table 73. Pfizer Company Details
    Table 74. Pfizer Business Overview
    Table 75. Pfizer Antihormonal Cancer Therapies Product
    Table 76. Pfizer Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 77. Pfizer Recent Development
    Table 78. Sanofi Company Details
    Table 79. Sanofi Business Overview
    Table 80. Sanofi Antihormonal Cancer Therapies Product
    Table 81. Sanofi Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 82. Sanofi Recent Development
    Table 83. Takeda Company Details
    Table 84. Takeda Business Overview
    Table 85. Takeda Antihormonal Cancer Therapies Product
    Table 86. Takeda Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 87. Takeda Recent Development
    Table 88. Roche Company Details
    Table 89. Roche Business Overview
    Table 90. Roche Antihormonal Cancer Therapies Product
    Table 91. Roche Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 92. Roche Recent Development
    Table 93. Amgen Company Details
    Table 94. Amgen Business Overview
    Table 95. Amgen Antihormonal Cancer Therapies Product
    Table 96. Amgen Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 97. Amgen Recent Development
    Table 98. Samyang Biopharmaceuticals Company Details
    Table 99. Samyang Biopharmaceuticals Business Overview
    Table 100. Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 101. Samyang Biopharmaceuticals Recent Development
    Table 102. Tolmar Company Details
    Table 103. Tolmar Business Overview
    Table 104. Tolmar Antihormonal Cancer Therapies Product
    Table 105. Tolmar Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 106. Tolmar Recent Development
    Table 107. Bluebird Bio Company Details
    Table 108. Bluebird Bio Business Overview
    Table 109. Bluebird Bio Antihormonal Cancer Therapies Product
    Table 110. Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 111. Bluebird Bio Recent Development
    Table 112. Bristol-Myers Squibb Company Details
    Table 113. Bristol-Myers Squibb Business Overview
    Table 114. Bristol-Myers Squibb Antihormonal Cancer Therapies Product
    Table 115. Bristol-Myers Squibb Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 116. Bristol-Myers Squibb Recent Development
    Table 117. Exelixis Company Details
    Table 118. Exelixis Business Overview
    Table 119. Exelixis Antihormonal Cancer Therapies Product
    Table 120. Exelixis Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 121. Exelixis Recent Development
    Table 122. Guardant Health Company Details
    Table 123. Guardant Health Business Overview
    Table 124. Guardant Health Antihormonal Cancer Therapies Product
    Table 125. Guardant Health Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 126. Guardant Health Recent Development
    Table 127. Illumina Company Details
    Table 128. Illumina Business Overview
    Table 129. Illumina Antihormonal Cancer Therapies Product
    Table 130. Illumina Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
    Table 131. Illumina Recent Development
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Antihormonal Cancer Therapies Market Share by Type: 2020 VS 2027
    Figure 2. Radiations Features
    Figure 3. Drugs Features
    Figure 4. Surgeries Features
    Figure 5. Others Features
    Figure 6. Global Antihormonal Cancer Therapies Market Share by Application: 2020 VS 2027
    Figure 7. Breast Cancer Case Studies
    Figure 8. Prostate Cancer Case Studies
    Figure 9. Other Case Studies
    Figure 10. Antihormonal Cancer Therapies Report Years Considered
    Figure 11. Global Antihormonal Cancer Therapies Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Antihormonal Cancer Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Antihormonal Cancer Therapies Market Share by Regions: 2020 VS 2027
    Figure 14. Global Antihormonal Cancer Therapies Market Share by Regions (2022-2027)
    Figure 15. Global Antihormonal Cancer Therapies Market Share by Players in 2020
    Figure 16. Global Top Antihormonal Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihormonal Cancer Therapies as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Antihormonal Cancer Therapies Revenue in 2020
    Figure 18. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2016-2021)
    Figure 19. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2022-2027)
    Figure 20. North America Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Antihormonal Cancer Therapies Market Share by Type (2016-2027)
    Figure 22. North America Antihormonal Cancer Therapies Market Share by Application (2016-2027)
    Figure 23. North America Antihormonal Cancer Therapies Market Share by Country (2016-2027)
    Figure 24. United States Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Antihormonal Cancer Therapies Market Share by Type (2016-2027)
    Figure 28. Europe Antihormonal Cancer Therapies Market Share by Application (2016-2027)
    Figure 29. Europe Antihormonal Cancer Therapies Market Share by Country (2016-2027)
    Figure 30. Germany Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Antihormonal Cancer Therapies Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Antihormonal Cancer Therapies Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Antihormonal Cancer Therapies Market Share by Region (2016-2027)
    Figure 40. China Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Antihormonal Cancer Therapies Market Share by Type (2016-2027)
    Figure 48. Latin America Antihormonal Cancer Therapies Market Share by Application (2016-2027)
    Figure 49. Latin America Antihormonal Cancer Therapies Market Share by Country (2016-2027)
    Figure 50. Mexico Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Antihormonal Cancer Therapies Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Antihormonal Cancer Therapies Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Antihormonal Cancer Therapies Market Share by Country (2016-2027)
    Figure 56. Turkey Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. AstraZeneca Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 60. Novartis Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 61. Pfizer Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 62. Sanofi Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 63. Takeda Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 64. Roche Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 65. Amgen Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 66. Samyang Biopharmaceuticals Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 67. Tolmar Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 68. Bluebird Bio Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 70. Exelixis Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 71. Guardant Health Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 72. Illumina Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Novartis
Pfizer
Sanofi
Takeda
Roche
Amgen
Samyang Biopharmaceuticals
Tolmar
Bluebird Bio
Bristol-Myers Squibb
Exelixis
Guardant Health
Illumina
Frequently Asked Questions
Antihormonal Cancer Therapies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antihormonal Cancer Therapies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antihormonal Cancer Therapies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Anti-fungal Drugs

Antifungal drugs are used to treat fungal infections, which most commonly affect your skin, hair  ... Read More